Key result
The circulating extracellular vesicle transcriptome is significantly altered during acute heart failure, with 4 lncRNAs dynamically responding to decongestion independent of weight changes.
Why the study?
Acute decompensation increases mortality in heart failure, but underlying etiologies remain unclear; researchers hypothesized extracellular vesicle transcriptomic cargo dynamically reflects molecular pathways from decompensated to recompensated states.
Does the plasma extracellular vesicle transcriptome change dynamically with decongestion in acute heart failure patients?
Observational (n=214)
Does the plasma extracellular vesicle transcriptome change dynamically with decongestion in acute heart failure patients?
The circulating extracellular vesicle transcriptome, particularly lncRNAs, changes dynamically during acute heart failure decongestion and reveals distinct cellular origins for HFrEF (cardiomyocyte) versus HFpEF (multi-organ).
Plasma EV lncRNA shifts during acute HF decongestion may track phenotype-specific origins; leaves open their role as dynamic biomarkers or targets.
Background Acute decompensation is associated with increased mortality in heart failure (HF) patients, though the underlying etiology remains unclear. Extracellular vesicles (EVs) and their cargo may mark specific cardiovascular physiologic states. We hypothesized that EV transcriptomic cargo, including long non-coding RNAs (lncRNAs) and mRNAs, is dynamic from the decompensated to recompensated HF state, reflecting molecular pathways relevant to adverse remodeling. Methods We examined differential RNA expression from circulating plasma extracellular RNA in acute HF patients at hospital admission and discharge alongside healthy controls. We leveraged different exRNA carrier isolation methods, publicly available tissue banks, and single nuclear deconvolution of human cardiac tissue to identify cell and compartment specificity of the topmost significantly differentially expressed targets. EV-derived transcript fragments were prioritized by fold change (−1.5 to + 1.5) and significance (<5% false discovery rate), and their expression in EVs was subsequently validated in 182 additional patients (24 control; 86 HFpEF; 72 HFrEF) by qRT-PCR. We finally examined the regulation of EV-derived lncRNA transcripts in human cardiac cellular stress models. Results We identified 138 lncRNAs and 147 mRNAs (present mostly as fragments in EVs) differentially expressed between HF and control. Differentially expressed transcripts between HFrEF vs. control were primarily cardiomyocyte derived, while those between HFpEF vs. control originated from multiple organs and different (non-cardiomyocyte) cell types within the myocardium. We validated 5 lncRNAs and 6 mRNAs to differentiate between HF and control. Of those, 4 lncRNAs (AC092656.1, lnc-CALML5-7, LINC00989, RMRP) were altered by decongestion, with their levels independent of weight changes during hospitalization. Further, these 4 lncRNAs dynamically responded to stress in cardiomyocytes and pericytes in vitro , with a directionality mirroring the acute congested state. Conclusion Circulating EV transcriptome is significantly altered during acute HF, with distinct cell and organ specificity in HFpEF vs. HFrEF consistent with a multi-organ vs. cardiac origin, respectively. Plasma EV-derived lncRNA fragments were more dynamically regulated with acute HF therapy independent of weight change (relative to mRNAs). This dynamicity was further demonstrated with cellular stress in vitro . Prioritizing transcriptional changes in plasma circulating EVs with HF therapy may be a fruitful approach to HF subtype-specific mechanistic discovery. CLINICAL PERSPECTIVE What is new? We performed extracellular transcriptomic analysis on the plasma of patients with acute decompensated heart failure (HFrEF and HFpEF) before and after decongestive efforts. Long non-coding RNAs (lncRNAs) within extracellular vesicles (EVs) changed dynamically upon decongestion in concordance with changes within human iPSC-derived cardiomyocytes under stress. In acute decompensated HFrEF, EV RNAs are mainly derived from cardiomyocytes, whereas in HFpEF, EV RNAs appear to have broader, non-cardiomyocyte origins. What are the clinical implications? Given their concordance between human expression profiles and dynamic in vitro responses, lncRNAs within EVs during acute HF may provide insight into potential therapeutic targets and mechanistically relevant pathways. These findings provide a “liquid biopsy” support for the burgeoning concept of HFpEF as a systemic disorder extending beyond the heart, as opposed to a more cardiac-focused physiology in HFrEF.
No takes yet. Share an insight, caveat, or question.
Gokulnath et al. (2023) conducted an observational in Acute decompensated heart failure (n=214). Acute decompensated heart failure and decongestion vs. Healthy controls was evaluated on Differential expression of EV-derived lncRNAs and mRNAs. The circulating extracellular vesicle transcriptome is significantly altered during acute heart failure, with 4 lncRNAs dynamically responding to decongestion independent of weight changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: